• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by EUDA Health Holdings Limited

    3/27/24 7:35:31 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care
    Get the next $EUDA alert in real time by email
    SC 13G 1 formsc13g.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO §240.13d-2

     

    EUDA HEALTH HOLDINGS LIMITED

    (Name of Issuer)

     

    ORDINARY SHARES, NO PAR VALUE

    (Title of Class of Securities)

     

    G3142E105

    (CUSIP Number)

     

    DECEMBER 31, 2023

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1 (b)
       
    ☐ Rule 13d-1 (c)
       
    ☒ Rule 13d-1 (d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Continued on following page(s))

    Page 1 of 9 Pages

     

     

     

     

     

     

    CUSIP No. G3142E105 13G Page 2 of 9 Pages

     

    1  

    NAME OF REPORTING PERSON

     

    TAN MENG DONG

    2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

    (a) ☒

    (b) ☐

    3  

    SEC USE ONLY

     

     

    4  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    SINGAPOREAN

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

      5  

    SOLE VOTING POWER

     

    6,502,525 ORDINARY SHARES (1) (2)

      6  

    SHARED VOTING POWER

     

    0

      7  

    SOLE DISPOSITIVE POWER

     

    6,502,525 ORDINARY SHARES (1) (2)

      8  

    SHARED DISPOSITIVE POWER

     

    0

    9  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    6,502,525 ORDINARY SHARES (1) (2)

    10  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    ☐

    11  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    26.40% (3)

    12  

    TYPE OF REPORTING PERSON*

     

    IN

     

    (1)EACH ORDINARY SHARE IS ENTITLED TO ONE VOTE PER SHARE.
    (2)INCLUDING 2,223,850 ORDINARY SHARES HELD BY 8I HOLDINGS 2 PTE. LTD.. AS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HOLDINGS 2 PTE. LTD., MR TAN HAS SOLE VOTING AND DISPOSITIVE POWER OVER THOSE SHARES. THE ADDRESS FOR 8I HOLDINGS 2 PTE LTD IS C/O 6 EU TONG SEN STREET #08-13 SINGAPORE 059817.
    (3)THE CALCULATIONS IN THE TABLE ABOVE ARE BASED ON 24,627,509 ORDINARY SHARES OUTSTANDING AS OF DECEMBER 31, 2023.

     

     

     

     

    CUSIP No. G3142E105 13G Page 3 of 9 Pages

     

    1  

    NAME OF REPORTING PERSON

     

    8I HOLDINGS 2 PTE. LTD.

    2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

    (a) ☒

    (b) ☐

    3  

    SEC USE ONLY

     

     

    4  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    SINGAPORE

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

      5  

    SOLE VOTING POWER

     

    2,223,850 ORDINARY SHARES (1) (2)

      6  

    SHARED VOTING POWER

     

    0

      7  

    SOLE DISPOSITIVE POWER

     

    2,223,850 ORDINARY SHARES (1) (2)

      8  

    SHARED DISPOSITIVE POWER

     

    0

    9  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,223,850 ORDINARY SHARES (1) (2)

    10  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    ☐

    11  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.03% (3)

    12  

    TYPE OF REPORTING PERSON*

     

    CO

     

    (1)EACH ORDINARY SHARE IS ENTITLED TO ONE VOTE PER SHARE.
    (2)AS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HOLDINGS 2 PTE. LTD., MR TAN HAS SOLE VOTING AND DISPOSITIVE POWER OVER THOSE SHARES. THE ADDRESS FOR 8I HOLDINGS 2 PTE LTD IS C/O 6 EU TONG SEN STREET #08-13 SINGAPORE 059817.
    (3)THE CALCULATIONS IN THE TABLE ABOVE ARE BASED ON 24,627,509 ORDINARY SHARES OUTSTANDING AS OF DECEMBER 31, 2023.

     

     

     

     

    Item 1.

     

      (a)

    Name of Issuer:

     

    EUDA HEALTH HOLDINGS LIMITED

     

      (b)

    (1) Address of Issuer’s Principal Executive Offices:

     

    1 PEMIMPIN DRIVE #12-06, ONE PEMIMPIN SINGAPORE 576151

     

    Item 2.

     

      (a) Name of Person Filing:

     

    The schedule 13g is filed by Tan Meng Dong, a Singapore individual, and 8i Holdings 2 Pte. Ltd. (“8i”), a Singapore company. Mr Tan is the sole shareholder and director of 8i Holdings 2 Pte. Ltd. and Mr Tan has sole voting and dispositive power over the reported shares.

     

      (b) Address of Principal Business Office or if none, Residence:

     

    Mr Tan and 8i have a business address of c/o 6 Eu Tong Sen Street #08-13 Singapore 059817.

     

      (c) Citizenship:

     

    MR TAN IS A SINGAPOREAN AND 8I IS A SINGAPORE COMPANY.

     

      (d)

    Title of Class of Securities:

     

    ORDINARY SHARES, NO PAR VALUE

     

      (e)

    CUSIP Number:

     

    G3142E105

     

    Item 3. Not Applicable

     

    Item 4. Ownership.

     

      (a) Amount Beneficially Owned:

     

    TAN MENG DONG – 6,502,525 (1)

     

    8I HOLDINGS 2 PTE. LTD. – 2,223,850 (2)

     

    (1)INCLUDING 2,223,850 ORDINARY SHARES HELD BY 8I HOLDINGS 2 PTE. LTD.. AS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HOLDINGS 2 PTE. LTD., MR TAN HAS SOLE VOTING AND DISPOSITIVE POWER OVER THOSE SHARES. THE ADDRESS FOR 8I HOLDINGS 2 PTE LTD IS C/O 6 EU TONG SEN STREET #08-13 SINGAPORE 059817.

     

    (2)AS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HOLDINGS 2 PTE. LTD., MR TAN HAS SOLE VOTING AND DISPOSITIVE POWER OVER THOSE SHARES. THE ADDRESS FOR 8I HOLDINGS 2 PTE LTD IS C/O 6 EU TONG SEN STREET #08-13 SINGAPORE 059817.

     

      (b) Percent of Class:

     

    TAN MENG DONG – 26.40% (1) (2)

     

    8I HOLDINGS 2 PTE. LTD. - 9.03% (1) (2)

     

    (1)INCLUDING 2,223,850 ORDINARY SHARES HELD BY 8I HOLDINGS 2 PTE. LTD.. AS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HOLDINGS 2 PTE. LTD., MR TAN HAS SOLE VOTING AND DISPOSITIVE POWER OVER THOSE SHARES. THE ADDRESS FOR 8I HOLDINGS 2 PTE LTD IS C/O 6 EU TONG SEN STREET #08-13 SINGAPORE 059817.

     

    (2)AS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HOLDINGS 2 PTE. LTD., MR TAN HAS SOLE VOTING AND DISPOSITIVE POWER OVER THOSE SHARES. THE ADDRESS FOR 8I HOLDINGS 2 PTE LTD IS C/O 6 EU TONG SEN STREET #08-13 SINGAPORE 059817.

     

     

     

     

      (c)

    Number of shares as to which such person has:

     

      (i) sole power to vote or to direct the vote:

     

    6,502,525 ORDINARY SHARES OF WHICH 4,278,675 ARE DIRECTLY OWNED BY TAN MENG DONG AND 2,223,850 ARE DIRECTLY OWNED BY 8I HOLDINGS 2 PTE. LTD. (MR TAN IS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HLDINGS 2 PTE. LTD., AND HAS SOLE VOTING AND DISPOSITIVE POWER OVER THE SHARES).

     

      (ii) shared power to vote or to direct the vote:

     

    0

     

      (iii) sole power to dispose or to direct the disposition of:

     

    6,502,525 ORDINARY SHARES OF WHICH 4,278,675 ARE DIRECTLY OWNED BY TAN MENG DONG AND 2,223,850 ARE DIRECTLY OWNED BY 8I HOLDINGS 2 PTE. LTD. (MR TAN IS THE SOLE SHAREHOLDER AND DIRECTOR OF 8I HLDINGS 2 PTE. LTD., AND HAS SOLE VOTING AND DISPOSITIVE POWER OVER THE SHARES).

     

      (iv) shared power to dispose or to direct the disposition of:

     

    0

     

    Item 5.

    Ownership of Five Percent or Less of a Class: NOT APPLICABLE

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following:

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person: NOT APPLICABLE

     

    Item 7. Identification and Classification of Subsidiary Which Acquired the Securities: NOT APPLICABLE

     

    Item 8. Identification and Classification of Members of the Group: NOT APPLICABLE

     

    Item 9. Notice of Dissolution of Group: NOT APPLICABLE

     

    Item 10.

    Certifications:

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    March 27, 2024

     

      TAN MENG DONG
       
      By /s/ TAN MENG DONG
      Name: TAN MENG DONG

     

      8I HOLDINGS 2 PTE. LTD.
       
      By /s/ TAN MENG DONG
      Name: TAN MENG DONG
      Title: SOLE SHAREHOLDER AND DIRECTOR

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, Provided, however, That a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

     

     

    Get the next $EUDA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EUDA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $EUDA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

      SINGAPORE, April 24, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, today announced an update to the potential strategic partnership, previously announced in December 2024, with Guangdong Cell Biotech Co. Ltd. ("Guangdong Cell Biotech"). Guangdong Cell Biotech is a prominent player in stem cell therapies and regenerative medicine in China. It develops autologous cell treatments and tailored medicines for various disorders. Instead of the initially contemplated joint venture, the parties have adopted a commercial

      4/24/25 7:00:00 AM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

      -        Preliminary Discussions Underway to Establish a Joint Venture SINGAPORE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it has entered into preliminary discussions with Guangdong Cell Biotech Co. Ltd. ("Guangdong Cell Biotech"), a prominent player in stem cell therapies and regenerative medicine, to form a joint venture. Guangdong Cell Biotech develops autologous cell treatments and tailored medicines for various disorders. This potential collaboration aims to leverage the complem

      12/16/24 5:00:00 PM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

      MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ:NRXP) will appear on the Emerging Growth Conference today in response to multiple requests and investor demand. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Jonathan Javitt, MD, MPH, Founder and Chairman will be discussing its first steps towards acquisition through its HOPE Therapeutics subsidiary of a national network of interventional psychiatry clinics focused on tr

      10/31/24 7:00:00 AM ET
      $CIA
      $EUDA
      $GOSS
      $LDTC
      Life Insurance
      Finance
      Medical/Nursing Services
      Health Care

    $EUDA
    SEC Filings

    See more
    • SEC Form 6-K filed by EUDA Health Holdings Limited

      6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

      6/2/25 8:00:09 AM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • SEC Form 20-F filed by EUDA Health Holdings Limited

      20-F - EUDA Health Holdings Ltd (0001847846) (Filer)

      4/29/25 2:28:41 PM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by EUDA Health Holdings Limited

      6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

      4/24/25 4:05:23 PM ET
      $EUDA
      Medical/Nursing Services
      Health Care

    $EUDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by EUDA Health Holdings Limited

      SC 13G - EUDA Health Holdings Ltd (0001847846) (Subject)

      3/27/24 7:35:31 AM ET
      $EUDA
      Medical/Nursing Services
      Health Care